SRSF1 and hnRNP H antagonistically regulate splicing of COLQ exon 16 in a congenital myasthenic syndrome

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Rahman, Mohammad Alinoor ^a   Azuma, Yoshiteru ^a   Nasrin, Farhana ^a   Takeda, Jun Ichi ^a   Nazim, Mohammad ^a   Ahsan, Khalid Bin ^a   Masuda, Akio ^a   Engel, Andrew G ^b   Ohno, Kinji ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; COLLAGEN; COLQ PROTEIN, HUMAN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN GROUP F H; HNRNPH2 PROTEIN, HUMAN; MUSCLE PROTEIN; PROTEIN BINDING; RNA SPLICING; SERINE ARGININE RICH SPLICING FACTOR; SRSF1 PROTEIN, HUMAN;

CONGENITAL MYASTHENIC SYNDROME; EXON; GENE EXPRESSION REGULATION; GENETICS; HELA CELL LINE; HUMAN; MUTATION; RNA SPLICING;

ACETYLCHOLINESTERASE; COLLAGEN; EXONS; GENE EXPRESSION REGULATION; HELA CELLS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP F-H; HUMANS; MUSCLE PROTEINS; MUTATION; MYASTHENIC SYNDROMES, CONGENITAL; PROTEIN BINDING; RNA SPLICE SITES; SERINE-ARGININE SPLICING FACTORS;

EID: 84939455168     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13208     Document Type: Article

References (51)

1. Engel, A. G., Ohno, K. & Sine, S. M. Sleuthing molecular targets for neurological diseases at the neuromuscular junction. Nat Rev Neurosci 4, 339-352 (2003).
2. Engel, A. G. Current status of the congenital myasthenic syndromes. Neuromuscul Disord 22, 99-111 (2012).
3. Hall, Z. W. Multiple forms of acetylcholinesterase and their distribution in endplate and non-endplate regions of rat diaphragm muscle. J Neurobiol 4, 343-361 (1973).
4. Ohno, K., Brengman, J., Tsujino, A. & Engel, A. G. Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme. Proc Natl Acad Sci USA 95, 9654-9659 (1998).
5. Ohno, K., Ohkawara, B., Ito, M. & Engel, A. G. Molecular Genetics of Congenital Myasthenic Syndromes. in eLS doi: 10.1002/9780470015902.a9780470024314 (John Wiley & Sons, Inc., 2014).
6. Ohno, K. et al. The spectrum of mutations causing endplate acetylcholinesterase deficiency. Ann Neurol 47, 162-170 (2000).
7. Peng, H. B., Xie, H., Rossi, S. G. & Rotundo, R. L. Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan. J Cell Biol 145, 911-921 (1999).
8. Cartaud, A. et al. MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction. J Cell Biol 165, 505-515 (2004).
9. Ito, M. et al. Protein-anchoring strategy for delivering acetylcholinesterase to the neuromuscular junction. Mol Ther 20, 1384-1392 (2012).
10. Engel, A. G. The therapy of congenital myasthenic syndromes. Neurotherapeutics 4, 252-257 (2007).
11. Liewluck, T., Selcen, D. & Engel, A. G. Beneficial Effects of Albuterol in Congenital Endplate Acetylcholinesterase Deficiency and Dok-7 Myasthenia. Muscle Nerve 44, 789-794 (2011).
12. Pandit, S. et al. Genome-wide analysis reveals SR protein cooperation and competition in regulated splicing. Mol Cell 50, 223-235 (2013).
13. Zhang, Z. & Krainer, A. R. Involvement of SR proteins in mRNA surveillance. Mol Cell 16, 597-607 (2004).
14. Huang, C. et al. Characterization and in vivo functional analysis of splice variants of cypher. J Biol Chem 278, 7360-7365 (2003).
15. Sun, S., Zhang, Z., Sinha, R., Karni, R. & Krainer, A. R. SF2/ASF autoregulation involves multiple layers of post-transcriptional and translational control. Nat Struct Mol Biol 17, 306-312 (2010).
16. Karni, R. et al. The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat Struct Mol Biol 14, 185-193 (2007).
17. Han, K., Yeo, G., An, P., Burge, C. B. & Grabowski, P. J. A combinatorial code for splicing silencing: UAGG and GGGG motifs. PLoS Biol 3, 843-860 (2005).
18. Chou, M. Y., Rooke, N., Turck, C. W. & Black, D. L. hnRNP H is a component of a splicing enhancer complex that activates a c-src alternative exon in neuronal cells. Mol Cell Biol 19, 69-77 (1999).
19. Caputi, M. & Zahler, A. M. SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D. EMBO J 21, 845-855 (2002).
20. Wang, E. M., Dimova, N. & Cambi, F. PLP/DM20 ratio is regulated by hnRNPH and F and a novel G-rich enhancer in oligodendrocytes. Nucleic Acids Res 35, 4164-4178 (2007).
21. Kimbell, L. M., Ohno, K., Engel, A. G. & Rotundo, R. L. C-terminal and heparin-binding domains of collagenic tail subunit are both essential for anchoring acetylcholinesterase at the synapse. J Biol Chem 279, 10997-11005 (2004).
22. Nakata, K. et al. DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms. Proc Natl Acad Sci USA 106, 15873-15878 (2009).
23. Liu, X. D. & Mertz, J. E. Hnrnp-L Binds a Cis-Acting Rna Sequence Element That Enables Intron-Independent Gene-Expression. Genes Dev 9, 1766-1780 (1995).
24. Sanford, J. R. et al. Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts. Genome Res 19, 381-394 (2009).
25. Caputi, M. & Zahler, A. M. SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D. EMBO J 21, 845-855 (2002).
26. Masuda, A. et al. hnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome. Hum Mol Genet 17, 4022-4035 (2008).
27. Huelga, S. C. et al. Integrative genome-wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteins. Cell Rep 1, 167-178 (2012).
28. Liu, H. X., Zhang, M. & Krainer, A. R. Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins. Genes Dev 12, 1998-2012 (1998).
29. Cooper, T. A., Wan, L. & Dreyfuss, G. RNA and disease. Cell 136, 777-793 (2009).
30. Gorlov, I. P., Gorlova, O. Y., Frazier, M. L. & Amos, C. I. Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers. Am J Hum Genet 73, 1157-1161 (2003).
31. Nasrin, F. et al. HnRNP C, YB-1 and hnRNP L coordinately enhance skipping of human MUSK exon 10 to generate a Wntinsensitive MuSK isoform. Sci Rep 4, 6841 (2014).
32. Shiomi, K. et al. CDK4 and cyclin D1 allow human myogenic cells to recapture growth property without compromising differentiation potential. Gene Ther 18, 857-866 (2011).
33. Wada, M. R., Inagawa-Ogashiwa, M., Shimizu, S., Yasumoto, S. & Hashimoto, N. Generation of different fates from multipotent muscle stem cells. Development 129, 2987-2995 (2002).
34. Hashimoto, N. et al. Immortalization of human myogenic progenitor cell clone retaining multipotentiality. Biochem Biophys Res Commun 348, 1383-1388 (2006).
35. Rahman, M. A. et al. HnRNP L and hnRNP LL antagonistically modulate PTB-mediated splicing suppression of CHRNA1 premRNA. Sci Rep 3, 2931 (2013).
36. Cartegni, L., Hastings, M. L., Calarco, J. A., de Stanchina, E. & Krainer, A. R. Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2. Am J Hum Genet 78, 63-77 (2006).
37. Cartegni, L. & Krainer, A. R. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 30, 377-384 (2002).
38. Kashima, T. & Manley, J. L. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat Genet 34, 460-463 (2003).
39. Kashima, T., Rao, N., David, C. J. & Manley, J. L. hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing. Hum Mol Genet 16, 3149-3159 (2007).
40. Kohtz, J. D. et al. Protein-protein interactions and 5'-splice-site recognition in mammalian mRNA precursors. Nature 368, 119-124 (1994).
41. Xiao, S. H. & Manley, J. L. Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. Genes Dev 11, 334-344 (1997).
42. Cao, W. H. & Garcia-Blanco, M. A. A serine/arginine-rich domain in the human U1 70k protein is necessary and sufficient for ASF/SF2 binding. J Biol Chem 273, 20629-20635 (1998).
43. Cho, S. Y. et al. Interaction between the RNA binding domains of Ser-Arg splicing factor 1 and U1-70K snRNP protein determines early spliceosome assembly. Proc Natl Acad Sci USA 108, 8233-8238 (2011).
44. Higuchi, R., Krummel, B. & Saiki, R. K. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res 16, 7351-7367 (1988).
45. Ohno, K. et al. Myasthenic syndromes in Turkish kinships due to mutations in the acetylcholine receptor. Ann Neurol 44, 234-241 (1998).
46. Das, R., Zhou, Z. & Reed, R. Functional association of U2 snRNP with the ATP-independent spliceosomal complex E. Mol Cell 5, 779-787 (2000).
47. Merkin, J., Russell, C., Chen, P. & Burge, C. B. Evolutionary dynamics of gene and isoform regulation in Mammalian tissues. Science 338, 1593-1599 (2012).
48. Trapnell, C., Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105-1111 (2009).
49. Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28, 511-515 (2010).
50. Katz, Y., Wang, E. T., Airoldi, E. M. & Burge, C. B. Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat Methods 7, 1009-1015 (2010).
51. Zhang, M. Q. Statistical features of human exons and their flanking regions. Hum Mol Genet 7, 919-932 (1998).